[Federal Register: April 7, 1998 (Volume 63, Number 66)]
[Notices]               
[Page 17017]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07ap98-105]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 21, 1997, Celegene 
Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............  I                          
4-Methoxyamphetamine (7411)................  I                          
Amphetamine (1100).........................  II                         
Methylphenidate (1724).....................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture amphetamine for distribution of the 
bulk active substances to its customers, 4-methoxyamphetamine as an 
intermediate in the manufacture of a non-controlled substance, 
methylphenidate for product research and development and 2,5-
dimethoxyamphetamine to develop, manufacture and sell compounds to 
pharmaceutical and agrochemical industries.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed on or before June 8, 1998.

    Dated: January 27, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-8983 Filed 4-6-98; 8:45 am]
BILLING CODE 4410-09-M